Literature DB >> 6259732

Morphiceptin (NH4-tyr-pro-phe-pro-COHN2): a potent and specific agonist for morphine (mu) receptors.

K J Chang, A Lillian, E Hazum, P Cuatrecasas, J K Chang.   

Abstract

The synthetic peptide NH2-Tyr-Pro-Phe-Pro-CONH2 (morphiceptin), which is the amide of a fragment of the milk protein beta-casein, has morphinelike activities and is highly specific for morphine (mu) receptors but not for enkephalin (delta) receptors. It is as active as morphine in the guinea pig ileum but much less active in the mouse and rat vas deferens. The discovery of this specific morphine receptor ligand substantiates the hypothesis of multiple opiate receptors. The ligand, which may be of physiological significance since a very similar, or identical, activity can be detected in enzymatic digests of beta-casein, may prove useful for further investigation of the functions of opiate receptor subtypes.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6259732     DOI: 10.1126/science.6259732

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  27 in total

1.  Stereochemical requirements for receptor recognition of the mu-opioid peptide endomorphin-1.

Authors:  M G Paterlini; F Avitabile; B G Ostrowski; D M Ferguson; P S Portoghese
Journal:  Biophys J       Date:  2000-02       Impact factor: 4.033

2.  Effects of morphiceptin in the medial preoptic area on male sexual behavior.

Authors:  L Matuszewich; J L Ormsby; J Moses; D S Lorrain; E M Hull
Journal:  Psychopharmacology (Berl)       Date:  1995-12       Impact factor: 4.530

3.  Conformational characteristics of receptor-selective opioid peptides. 1H n.m.r. and c.d. spectroscopic studies of delta-kephalin and [Val4]morphiceptin.

Authors:  M Doi; M Tanaka; K Ikuma; M Nabae; K Kitamura; M Inoue; T Ishida
Journal:  Biochem J       Date:  1988-04-15       Impact factor: 3.857

4.  Identification of a novel opioid peptide (Tyr-Val-Pro-Phe-Pro) derived from human alpha S1 casein (alpha S1-casomorphin, and alpha S1-casomorphin amide).

Authors:  M Kampa; S Loukas; A Hatzoglou; P Martin; P M Martin; E Castanas
Journal:  Biochem J       Date:  1996-11-01       Impact factor: 3.857

Review 5.  Biologically active peptides in milk proteins.

Authors:  H Meisel; H Frister; E Schlimme
Journal:  Z Ernahrungswiss       Date:  1989-12

6.  Biomolecular information analysis in neurotransmitter systems.

Authors:  S C Brooks
Journal:  Acta Biotheor       Date:  1984       Impact factor: 1.774

Review 7.  Casein, a prohormone with an immunomodulating role for the newborn?

Authors:  D Migliore-Samour; P Jollès
Journal:  Experientia       Date:  1988-03-15

8.  How do tranquilizing agents selectively inhibit conditioned avoidance responding?

Authors:  D M Grilly; S K Johnson; R Minardo; D Jacoby; J LaRiccia
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

9.  Opiates and classical conditioning: selective abolition of conditioned responses by activation of opiate receptors within the central nervous system.

Authors:  M D Mauk; J Madden; J D Barchas; R F Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

10.  Differential epileptogenic potentials of selective mu and delta opiate receptor agonists.

Authors:  J Haffmans; M R Dzoljic
Journal:  J Neural Transm       Date:  1983       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.